
|Articles|June 17, 2021
TrialAssure Releases TrialAssure LINK
Advertisement
TrialAssure has announced the release of TrialAssure LINK software for the development, review, translation and publishing of plain language, or lay summaries.
Key features of LINK include the ability to:
- Create ready-to-review lay summaries through preconfigured data feeds
- Manage workflows by serving as a comprehensive project management solution
- Maximize re-use of clinical trial data, speeding the process and enhancing data integrity
- Adhere to best practices using lay term glossaries, readability analytics, and auto-generated graphics, charts, and images
- Apply and review translations consistent with languages spoken by clinical trial participants
- Meet global transparency demands
TrialAssure LINK is a core application within The Ultimate Transparency Suite along with existing applications that include TrialAssure REGISTRY, TrialAssure ANONYMIZE, and TrialAssure BEACON.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
2
ACT Brief: Rethinking Representation in Cancer Trials, Positive Phase IIb SLE Data, and a Major Obesity Drug Partnership
3
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
4
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
5




